Acadia Healthcare (NASDAQ:ACHC) Stock Rating Upgraded by Raymond James Financial

Acadia Healthcare (NASDAQ:ACHC) was upgraded by analysts at Raymond James Financial from an “outperform” rating to a “strong-buy” rating in a research report issued on Monday. The firm presently has a $39.00 target price on the stock. Raymond James Financial’s price target indicates a potential upside of 40.04% from the stock’s current price.

ACHC has been the topic of a number of other research reports. UBS Group raised their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the stock a “buy” rating in a research note on Friday, April 17th. Jefferies Financial Group reaffirmed a “hold” rating and set a $24.50 price objective on shares of Acadia Healthcare in a research note on Monday, April 20th. Barclays raised their price objective on shares of Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday. Zacks Research raised shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. Finally, Royal Bank Of Canada raised their price objective on shares of Acadia Healthcare from $17.00 to $28.00 and gave the stock an “outperform” rating in a research note on Thursday, February 26th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $25.12.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $27.85 on Monday. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $28.57. The company’s 50 day moving average is $24.43 and its 200 day moving average is $19.12. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The company has a market cap of $2.56 billion, a PE ratio of -2.28, a price-to-earnings-growth ratio of 9.39 and a beta of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.09. The company had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. Acadia Healthcare’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, sell-side analysts forecast that Acadia Healthcare will post 1.48 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC lifted its position in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares in the last quarter. Hantz Financial Services Inc. lifted its position in shares of Acadia Healthcare by 501.9% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after buying an additional 1,822 shares in the last quarter. Wells Fargo & Company MN lifted its position in shares of Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after buying an additional 1,510 shares in the last quarter. Quent Capital LLC purchased a new position in shares of Acadia Healthcare during the 3rd quarter valued at approximately $71,000. Finally, Bayforest Capital Ltd purchased a new position in shares of Acadia Healthcare during the 4th quarter valued at approximately $52,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.